Suchergebnisse - "Schoergenhofer, Christian"

PubPharm (19)

1

The Pharmacokinetics of Individual Conjugated Xanthohumol Metabolites Show Efficient Glucuronidation and Higher Bioavailability of Micellar than Native Xanthohumol in a Randomized, Double-Blind, Crossover Trial in Healthy Humans

enthalten in: Molecular nutrition & food research | 2023

von Buckett, L. | Sus, N. | Spindler, V. | +3

2

Micellar Curcumin : Pharmacokinetics and Effects on Inflammation Markers and PCSK-9 Concentrations in Healthy Subjects in a Double-Blind, Randomized, Active-Controlled, Crossover Trial

enthalten in: Molecular nutrition & food research | 2022

von Grafeneder, J. | Derhaschnig, U. | Eskandary, F. | +5

3

Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2021

von Eber, E. | Trawinska-Bartnicka, M. | Sands, D. | +9

4

Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo

enthalten in: Thrombosis and haemostasis | 2020

von Buchtele, N. | Kovacevic, K. | Brostjan, C. | +6

5

Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid

enthalten in: The Journal of investigative dermatology | 2019

von Freire, P. | Muñoz, C. | Derhaschnig, U. | +8

6

Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers

enthalten in: Scientific reports | 2019

von Schoergenhofer, C. | Buchtele, N. | Gelbenegger, G. | +7

7

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial

enthalten in: British journal of haematology | 2019

von Gisslinger, H. | Buxhofer-Ausch, V. | Hodisch, J. | +19

8

A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

enthalten in: Clinical pharmacology and therapeutics | 2018

von Bartko, J. | Schoergenhofer, C. | Schwameis, M. | +8

9

Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia

enthalten in: Thrombosis and haemostasis | 2018

von Schoergenhofer, C. | Schwameis, M. | Gelbenegger, G. | +7

10

Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects : Food Intake and Comparison With a Reference Product

enthalten in: Clinical pharmacology in drug development | 2018

von Petrides, P. | Schoergenhofer, C. | Widmann, R. | +2